Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 624 clinical trials in Dordrecht, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
The NetherlandsStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
The NetherlandsStudy on LAVA-1207 and Pembrolizumab for Patients with Advanced Prostate Cancer Resistant to Treatment
The NetherlandsStudy on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer
The NetherlandsStudy on Anifrolumab for Adults with Chronic or Subacute Cutaneous Lupus Erythematosus Unresponsive to Antimalarial Therapy
The NetherlandsStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
The NetherlandsStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
The NetherlandsStudy on the Effects of Belimumab and Rituximab for Patients with Severe Systemic Lupus Erythematosus
The NetherlandsStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
The NetherlandsStudy on the Safety of Acoramidis in Patients with Transthyretin Amyloid Cardiomyopathy Who Completed a Previous Trial
The NetherlandsStudy on the Safety and Effectiveness of BOOST Cells for Treating Severe Osteogenesis Imperfecta in Children Before and After Birth
The NetherlandsStudy Comparing Carfilzomib, Lenalidomide, and Dexamethasone with Lenalidomide and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Acute Myeloid Leukemia (AML) and various forms of Multiple Myeloma, evaluating novel drug combinations and treatment approaches for patients ineligible for intensive chemotherapy.
Studies aim to improve survival rates and treatment outcomes in previously untreated patients.
Research centered on atherosclerotic cardiovascular disease and deep vein thrombosis, investigating new therapeutic approaches and preventive strategies.
Clinical trials focus on improving patient outcomes through innovative treatments and prevention strategies.
Studies examining treatments for thyroid conditions and hormonal disorders, comparing conventional and innovative therapeutic approaches.
Research aims to enhance treatment efficacy while minimizing side effects.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
